Cardlytics (CDLX) Tops Q1 EPS by 17c

Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.38), $0.17 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $67.9 million versus the consensus estimate of $64.66 million.

GUIDANCE:

Cardlytics sees Q2 2022 revenue of $73-80 million, versus the consensus of $74.7 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Palladyne AI reports preliminary Q2 revenue of ~$5.8M
• Keurig Dr Pepper (KDP) PT Raised to $39 at Bernstein SocGen Group